1-[(5,8-DIMETHOXY-7-METHYL-NAPHTHALEN-2-YL)-METHYL]-1,3-DIMETHYL-3,7-DIHYDRO-1H-PURINE-2,6-DIONE
Compound with spectra: 1 NMR
![1-[(5,8-DIMETHOXY-7-METHYL-NAPHTHALEN-2-YL)-METHYL]-1,3-DIMETHYL-3,7-DIHYDRO-1H-PURINE-2,6-DIONE](/api/compound/KX4htVI4JK5.png?ph=true&h=300&w=458 "1-[(5,8-DIMETHOXY-7-METHYL-NAPHTHALEN-2-YL)-METHYL]-1,3-DIMETHYL-3,7-DIHYDRO-1H-PURINE-2,6-DIONE")
| SpectraBase Compound ID | KX4htVI4JK5 |
|---|---|
| InChI | InChI=1S/C21H22N4O4/c1-12-8-16(28-4)14-7-6-13(9-15(14)18(12)29-5)10-25-20(26)17-19(22-11-23(17)2)24(3)21(25)27/h6-9,11H,10H2,1-5H3 |
| InChIKey | YMQJLEIIFXQRMW-UHFFFAOYSA-N |
| Mol Weight | 394.43 g/mol |
| Molecular Formula | C21H22N4O4 |
| Exact Mass | 394.164105 g/mol |
| Copyright | Copyright © 2016-2024 W. Robien, Inst. of Org. Chem., Univ. of Vienna. All Rights Reserved. |
|---|---|
| Solvent | CDCl3 |
7-[(5,8-DIMETHOXY-7-METHYL-NAPHTHALEN-2-YL)-METHYL]-1,3-DIMETHYL-3,7-DIHYDRO-1H-PURINE-2,6-DIONE
3,7-DIMETHYL-1-[(7-METHYL-5,8-DIOXO-5,8-DIHYDRO-NAPHTHALEN-2-YL)-METHYL]-3,7-DIHYDRO-1H-PURINE-2,6-DIONE
1-[(6-chloranyl-1,3-benzodioxol-5-yl)methyl]-3-methyl-7-(phenylmethyl)purine-2,6-dione
7-[(1,4-DIOXO-1,4-DIHYDRO-NAPHTHALEN-2-YL)-METHYL]-3,7-DIMETHYL-3,7-DIHYDRO-1H-PURINE-2,6-DIONE
1-[1-(3,4-dichlorobenzyl)-3,7-dimethyl-2,6-dioxo-2,3,6,7-tetrahydro-1H-purin-8-yl]-4-piperidinecarboxamide
8-(1,3-benzodioxol-5-yloxy)-1-benzyl-3,7-dimethyl-3,7-dihydro-1H-purine-2,6-dione
1-(2,4-dichlorobenzyl)-3,7-dimethyl-8-{[3-(4-morpholinyl)propyl]amino}-3,7-dihydro-1H-purine-2,6-dione
3,4,5-trimethoxybenzaldehyde [1-(3,4-dichlorobenzyl)-3,7-dimethyl-2,6-dioxo-2,3,6,7-tetrahydro-1H-purin-8-yl]hydrazone
8-[benzyl(methyl)amino]-1-(4-chlorobenzyl)-3,7-dimethyl-3,7-dihydro-1H-purine-2,6-dione
1-[1-(3-bromobenzyl)-3,7-dimethyl-2,6-dioxo-2,3,6,7-tetrahydro-1H-purin-8-yl]-4-piperidinecarboxamide
| Title | Journal or Book | Year |
|---|---|---|
| Preparations of Anthraquinone and Naphthoquinone Derivatives and Their Cytotoxic Effects | Chemical and Pharmaceutical Bulletin | 2011 |